How many patents does
Oklahoma Medical Research Foundation have?
patents
409
families
78
granted
89
applications
320
US
120
EP
74
WO
58
JP
17
CN
11
KR
6
RoW
123
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Oklahoma Medical Research Foundation
Top ten assignees appearing on patents
2009 - 2018
| selexys pharmaceuticals corporation | 27 |
| crescendo bioscience | 18 |
| comentis | 10 |
| novartis | 6 |
| intergenetics | 2 |
| meso scale technologies | 2 |
| colorado seminary | 1 |
Oklahoma Medical Research Foundation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| monoclonal antibodies against activated and unactivated protein c | 31 | 2007 |
| anti-p-selectin antibodies and methods of their use and identification | 27 | 2006 |
| methods for treating brain injury | 19 | 2011 |
| anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases | 17 | 2006 |
| hematopoietic stem cells treated by in vitro fucosylation and methods of use | 17 | 2003 |
| adrenocorticotropic hormone analogs and related methods | 16 | 2004 |
| human streptococcus pneumoniae antibodies and uses therefor | 16 | 2012 |
| methods for treating acute acoustic trauma | 15 | 2009 |
| biomarkers and methods for measuring and monitoring inflammatory disease activity | 15 | 2009 |
| 2, 4-disulfonyl pheny tert-butyl nitrone for the treatment of gliomas | 15 | 2008 |